News: Gland Pharma, a leading pharmaceutical company, recently announced its Q3 results for the fiscal year 2024. Let’s dive into the key highlights and understand the company’s performance during this period.
Mr. Srinivas Sadu, MD & CEO of Gland Pharma, expressed optimism:
“With strong results in the third quarter, we continued our positive momentum for the fiscal year. Our consolidated Q3 FY24 reported sales of INR 15,452 million, reflecting a quarter-on-quarter increase of 13% and a year-on-year increase of 65%. We achieved a consolidated EBITDA of INR 3,557 million and a consolidated net profit of INR 1,919 million.
Get the latest entertainment news with Sarkari Result! Be the first to know about celebrities and get thoughtful movie reviews. Stay connected with the fast-paced world of entertainment through Sarkari Exam.
Gland Pharma specializes in complex injectables, NCE-1s, First-to-File products, and 505(b)(2) filings. The company’s presence across the value chain has helped it witness exponential growth. Its professional management team, along with the support of global pharmaceutical major Shanghai Fosun Pharma, positions Gland Pharma as a key player in the pharmaceutical research, development, manufacturing, and marketing of injectables.
Gland Pharma’s reach extends to 60 countries, making it a reliable partner for healthcare providers worldwide. Its focus on innovation, quality, and affordability ensures that patients receive the best possible treatment.
Gland Pharma’s scientifically curated strategy aims to deliver long-term value for employees, shareholders, and investors. By integrating research and development, manufacturing, and marketing, the company continues to make significant contributions to the pharmaceutical industry.
Gland Pharma’s robust financials and strategic moves position it well for future growth. Amid market volatility, the company’s focus on innovation and global expansion remains unwavering. Investors can look forward to a promising journey ahead.
Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.
Note: All informations like net worths, obituary, web series release date, health & injury, relationship news & gaming or tech updates are collected using data drawn from public sources ( like social media platform , independent news agency ). When provided, we also incorporate private tips and feedback received from the celebrities ( if available ) or their representatives. While we work diligently to ensure that our article information and net worth numbers are as accurate as possible, unless otherwise indicated they are only estimates. We welcome all corrections and feedback using the button below.
Advertisement